2026-10-18T23:56:46Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/184642026-10-18T20:56:35Zopenairedrivercom_ebyu_10000col_ebyu_10001

Hipoglisemi Riski Altındaki Yenidoğanların Yönetimi ve Tedavisikorkmaz, leventAlan, CumaliPediatriHypoglycemia occurring between the first hours and days after \rbirth continues to be one of the most common findings in neonatal cases in our country. In many cases, hypoglycemia represents the normal physiological transition to extrauterine life, \rbut longer term hypoglycemia may be experienced in another \rgroup of patients. Although years have passed since the last review was published on this topic, the basic questions regarding \rneonatal hypoglycemia have largely remained the same. The \rnew consideration in the current article is that the transitional \rphase expression (first 72 hours after birth) defines a blood glucose level of less than 46.8mg/dL in the first 72 hours after birth, \runlike that mentioned in previous studies. This change helps in \rdistinguishing hypoglycemia associated with normal transition \rfrom persistent hypoglycemia defined by blood glucose levels \rof less than 59.4mg/dL in the first 72 hours after birth. This article reviews screening, monitoring, and intervention protocols \rto better identify, manage, and treat infants at risk of persistent, \rrecurrent, or severe hypoglycemia.2021Review Articlehttps://rdlopen.rawdatalibrary.net/r/ebyu/18464https://doi.org/10.5152/abcr.2021.200322687-4520trArchives of Basic and Clinical Researchinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/reviewhttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/18464